SARS-CoV-2 biological clones are genetically heterogeneous and include clade-discordant residues
Journal of Virology · 2025
DOI: 10.1128/jvi.02250-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2025. Verfasst von Ana Isabel de Ávila und 13 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Biología Molecular "Severo Ochoa" (CSIC-UAM), Campus de Cantoblanco, Madrid, Spain. Hauptthemen laut MEDLINE: SARS-CoV-2. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Defective genomes are part of SARS-CoV-2 quasispecies. High-resolution, ultra-deep sequencing of bulk RNA from viral populations does not distinguish RNA mutations, insertions, and deletions in viable genomes from those in defective genomes. To quantify SARS-CoV-2 infectious variant progeny, virus from four individual plaques (biological clones) of a preparation of isolate USA-WA1/2020, formed on Vero E6 cell monolayers, was subjected to further biological cloning to yield 9 second-generation and 15 third-generation sub-clones. Consensus genomic sequences of the biological clones and sub-clones included an average of 2.8 variations per viable genome, relative to the consensus sequence of the parental USA-WA1/2020 virus. This value is 6.5-fold lower than the estimates for biological clones of other RNA viruses such as bacteriophage Qβ, foot-and-mouth disease virus, or hepatitis C virus in cell culture. The mutant spectrum complexity of the nsp12 (polymerase)- and spike (S)-coding region was unique in the progeny of each of 10 third-generation sub-clones; they shared 2.4% of the total of 164 different mutations and deletions scored in the 3,719 genomic residues that were screened. The presence of minority out-of-frame deletions revealed the ease of defective genome production from an individual infectious genome. Several low-frequency point mutations and deletions were clade-discordant in that they were not typical of USA-WA1/2020 but served to define the consensus sequences of future SARS-CoV-2 clades. Implications for SARS-CoV-2 adaptability and COVID-19 control of the viable genome heterogeneity and the generation of complex mutant spectra from individual genomes are discussed. IMPORTANCE Sequencing of biological clones is a means to identify mutations, insertions, and deletions located in viable genomes. This distinction is particularly important for viral populations, such as those of SARS-CoV-2, that contain large proportions of defective genomes. By sequencing biological clones and sub-clones, we quantified the heterogeneity of the viable complement of USA-WA1/2020 to be lower than exhibited by other RNA viruses. This difference may be due to a reduced mutation rate or to limited tolerance of the large coronavirus genome to incorporate mutations and deletions and remain functional or a combination of both influences. The presence of clade-discordant residues in the progeny of individual biological sub-clones suggests limitations in the occupation of sequence space by SARS-CoV-2. However, the complex and unique mutant spectra that are rapidly generated from individual genomes suggest an aptness to confront selective constraints.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centro de Biología Molecular "Severo Ochoa" (CSIC-UAM), Campus de Cantoblanco, Madrid, Spain.
- Department of Clinical Microbiology, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
- Department of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-CSIC), Consejo Superior de Investigaciones Científicas (CSIC), Campus de Cantoblanco, Madrid, Spain.
- Departamento de Biología Molecular, Universidad Autonoma de Madrid, Campus de Cantoblanco, Madrid, Spain.
- Department of Genetics and Genomics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
- Center for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
ORCID-Profile: Ana Isabel de Ávila, María Eugenia Soria, Pilar Somovilla, Pablo Mínguez, Llanos Salar-Vidal, Marta Martín-García, Sonia Zuñiga, Isabel Sola, Luis Enjuanes, Ignacio Gadea, Celia Perales, Esteban Domingo
Zitieren
APA
de Ávila, A. I., Soria, M. E., Martínez-González, B., Somovilla, P., Mínguez, P., Salar-Vidal, L., Esteban-Muñoz, M., Martín-García, M., Zuñiga, S., Sola, I., Enjuanes, L., Gadea, I., Perales, C., & Domingo, E. (2025). SARS-CoV-2 biological clones are genetically heterogeneous and include clade-discordant residues. Journal of Virology. https://doi.org/10.1128/jvi.02250-24
Vancouver
de Ávila AI, Soria ME, Martínez-González B, Somovilla P, Mínguez P, Salar-Vidal L, et al. SARS-CoV-2 biological clones are genetically heterogeneous and include clade-discordant residues. Journal of Virology. 2025. doi:10.1128/jvi.02250-24
BibTeX
@article{devila2025,
author = {de Ávila, Ana Isabel and Soria, María Eugenia and Martínez-González, Brenda and Somovilla, Pilar and Mínguez, Pablo and Salar-Vidal, Llanos and Esteban-Muñoz, Mario and Martín-García, Marta and Zuñiga, Sonia and Sola, Isabel and Enjuanes, Luis and Gadea, Ignacio and Perales, Celia and Domingo, Esteban},
title = {SARS-CoV-2 biological clones are genetically heterogeneous and include clade-discordant residues},
journal = {Journal of Virology},
year = {2025},
doi = {10.1128/jvi.02250-24}
}
EUVIMED